Larson Financial Group’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.43K Buy
331
+33
+11% +$718 ﹤0.01% 2447
2026
Q1
$5.17K Sell
298
-15
-5% -$284 ﹤0.01% 2596
2025
Q4
$5.9K Buy
313
+236
+306% +$3.95K ﹤0.01% 2390
2025
Q3
$1.12K Buy
+77
New +$1.1K ﹤0.01% 2887

Other funds holding CDNA

Larson Financial Group's CDNA Position: Q2 2026 in Review

Larson Financial Group increased its CareDx (CDNA) stake by 11% in Q2 2026, buying an estimated $718 and bringing the position to 331 shares worth $9.43K. The position accounts for ﹤0.01% of the portfolio, ranked #2447.

Larson Financial Group first reported a position in CDNA in Q3 2025 and has held it in 4 quarters since. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • Larson Financial Group held 331 shares of CareDx worth $9.43K as of Q2 2026.
  • Larson Financial Group bought 33 CareDx shares in Q2 2026, an estimated $718.
  • CareDx made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #2447 holding.
  • Larson Financial Group first reported a position in CareDx in Q3 2025 and has held it in 4 quarters since.
  • 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.